GENE TARGETING IN HEMOSTASIS. PROTHROMBIN
William Y. Sun and Sandra J. F. Degen
Division of Developmental Biology, Children's Hospital Research Foundation, Cincinnati, OH 45229
TABLES
Table 1. Properties of Prothrombin
|
Functions |
Substrates or target cells |
|
Coagulation |
Fibrinogen |
|
|
Factor XIII |
|
|
Platelets (PARs and integrin aIIbb3) |
|
Anticoagulation |
Protein C |
|
|
Factors Va and VIIIa |
|
Inflammation |
Monocytes |
|
|
Macrophages |
|
Atherosclerosis/restenosis |
Vascular smooth muscle cells |
|
|
Endothelial cells |
|
CNS functions/response to injury |
Neurons |
|
|
Astrocytes |
|
|
Synapses |
|
Tissue repair |
Fibroblasts |
|
|
Endothelial cells |
|
Mitogen |
Fibroblasts |
|
|
Endothelial cells |
|
|
Astrocytes |
|
|
Vascular smooth muscle cells |
Table 2. Comparison of the lengths of exons and introns in the genes coding for human, bovine and mouse prothrombin1
|
Exon |
Human amino acids |
Human
Gene2
(bp) |
Bovine Gene 3
(bp) |
Mouse
Gene (bp) |
Intron |
Human Gene2
(bp) |
Bovine Gene 3 (bp) |
Mouse Gene (bp) |
|
1 |
-43 to -17 |
79+4 |
94+5 |
79+4 |
A |
386 |
342 |
376 |
|
2 |
-17 to 37 |
161 |
164 |
164 |
B |
659 |
601+/- 62 |
579 |
|
3 |
38-46 |
25 |
25 |
25 |
C |
242 |
227 |
221 |
|
4 |
46-63 |
51 |
51 |
51 |
D |
2326 |
1504+/-73 |
1600 |
|
5 |
63-98 |
106 |
106 |
106 |
E |
96 |
98 |
78 |
|
6 |
98-144 |
137 |
137 |
137 |
F |
2338 |
1381+/-99 |
2146 |
|
7 |
144-249 |
315 |
315 |
318 |
G |
324 |
293 |
242 |
|
8 |
249-292 |
129 |
135 |
114 |
H |
84 |
75 |
76 |
|
9 |
292-334 |
127 |
127 |
127 |
I |
1157 |
1055+/-94 |
631 |
|
10 |
334-390 |
168 |
168 |
168 |
J |
497 |
397+/-46 |
317 |
|
11 |
390-448 |
174 |
174 |
ND |
K |
542 |
242 |
ND |
|
12 |
448-509 |
182 |
182 |
ND |
L |
9447 |
6940+/-255 |
ND |
|
13 |
509-532 |
71 |
71 |
ND |
M |
146 |
135 |
128 |
|
14 |
533-polyA |
241 |
266 |
253 |
|
|
|
|
ND: A portion of the mouse prothrombin gene was not isolated and therefore not characterized; this included exons 11-13 and intervening sequences K and L. 1 All sizes were determined by DNA sequence analysis, except for those in the bovine gene indicated with standard deviations which were determined by heteroduplex analysis with the electron microscope. 2 Reference 93 3 Reference 95 4 Due to variability in the transciption start site the size of the exon is indicated as starting at the initiator methionine 5 The length of exon 1 is indicated as the size starting in the 5' flanking region where the longest cDNA started.
Table 3. Exon-intron junctions in the mouse prothrombin gene1
|
E1 |
A |
T |
G |
G |
T |
A |
A |
G |
G |
|
|
|
|
C |
T |
G |
C |
A |
G |
T |
G |
T |
E2 |
|
E2 |
A |
C |
A |
G |
T |
G |
A |
G |
T |
|
|
|
|
T |
T |
G |
T |
A |
G |
G |
A |
C |
E3 |
|
E3 |
C |
A |
G |
G |
T |
G |
A |
G |
T |
|
|
|
|
T |
T |
T |
T |
A |
G |
G |
A |
C |
E4 |
|
E4 |
A |
A |
G |
G |
T |
G |
G |
G |
G |
|
|
|
|
C |
T |
G |
T |
A |
G |
G |
T |
C |
E5 |
|
E5 |
T |
G |
A |
G |
T |
G |
A |
G |
T |
|
|
|
|
T |
T |
A |
C |
A |
G |
A |
A |
T |
E6 |
|
E6 |
G |
T |
G |
G |
T |
G |
A |
G |
C |
|
|
|
|
C |
A |
C |
C |
A |
G |
G |
C |
C |
E7 |
|
E7 |
G |
C |
G |
G |
T |
G |
A |
G |
C |
|
|
|
|
C |
T |
A |
C |
A |
G |
A |
G |
G |
E8 |
|
E8 |
C |
A |
G |
G |
T |
G |
A |
G |
A |
|
|
|
|
C |
T |
G |
C |
A |
G |
A |
C |
T |
E9 |
|
E9 |
C |
T |
G |
G |
T |
G |
C |
G |
T |
|
|
|
|
C |
G |
T |
T |
A |
G |
G |
C |
A |
E10 |
|
E10 |
C |
A |
G |
G |
T |
A |
T |
G |
A |
|
|
|
|
G |
C |
A |
C |
A |
G |
A |
T |
A |
E11 |
|
E11 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
E12 |
|
E12 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
E13 |
|
E13 |
A |
A |
G |
G |
T |
A |
T |
G |
C |
|
|
|
|
C |
C |
T |
C |
A |
G |
A |
G |
C |
E14 |
1
Exons 11 and 12 and the corresponding intervening sequences have not been isolated
Table 4. Genotypes of embryos and pups from matings of mice hemizygous for the targeted prothrombin allele (FII+/- x FII+/-)
|
Prothrombin Genotype |
|
Stage |
Total |
Genotyped |
+/+ |
+/- |
-/- |
%1 |
|
E8.5 |
37 |
34 |
10 |
16 |
8 |
23.5 |
|
E9.5 |
76 |
73 |
15 |
39 |
18 |
25.4 |
|
E10.5 |
104 |
103 |
29 |
58 |
7 |
6.8 |
|
E11.5 |
36 |
32 |
6 |
19 |
3 |
9.4 |
|
E12.5 |
99 |
86 |
26 |
46 |
8 |
9.3 |
|
E15.5 |
53 |
48 |
19 |
24 |
5 |
10.4 |
|
E18.5 |
96 |
95 |
34 |
51 |
10 |
10.5 |
|
Term |
135 |
134 |
47 |
77 |
10 |
7.4 |
1Viable prothrombin-deficient mice calculated as the percentage of all genotyped mice in the same age group.
Table 5. Coagulation assays on plasma isolated from wild-type mice and mice hemizygous (FII+/-) and homozygous (FII-/-) for the targeted prothrombin allele
|
Genotype |
Prothrombin time (sec) |
Thrombin time (sec) |
|
Wild-type |
16.1 +/- 1.6 |
7.3 +/- 1.4 |
|
FII+/- |
19.9 +/- 14.7 |
6.2 +/- 0.75 |
|
FII-/- |
>240 |
6.0 +/- 0.58 |
|
FII+/- + FII-/- |
15.4 +/- 2.1 |
ND |